Latest News for: eli

Edit

Elis: Disclosure of trading in own shares occured from February 16 to February 20, 2026

Nasdaq Globe Newswire 24 Feb 2026
Disclosure of trading in own shares occurred. from February 16 to February 20, 2026 ... .
Edit

Sources: QB Rivers follows dad Philip to NC State

ESPN 24 Feb 2026
Four-star quarterback Gunner Rivers, son of NC State legend and eight-time NFL Pro Bowler Philip Rivers, has committed to the Wolfpack, sources told ESPN on Monday ... .
Edit

Panther swimmer Eli Somers places 8th

Great Bend Tribune 23 Feb 2026
LENEXA — Great Bend Panther Eli Somers placed eighth (1.58.94) in the ...
Edit

Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly's in trial

CNBC 23 Feb 2026
Novo Nordisk stock fell as much as 10% Monday after it said its next-generation weight loss drug didn't meet its primary target ... .
Edit

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses ...

CNBC 23 Feb 2026
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug ... .
Edit

Novo Nordisk Stock Falls 15% After 'CargiSema' Fails To Match Eli Lilly's Weight Loss Drug

NDTV 23 Feb 2026
"CargiSema could not achieve its primary endpoint of demonstrating non-inferiority on weight loss." ... .
Edit

Novo Nordisk says weight loss drug fails to match Eli Lilly's in trial

CNBC 23 Feb 2026
CNBC's Annika Kim Constantino delivers the latest news surrounding Novo Nordisk ... .
Edit

Eli Lilly’s Zepbound Gets FDA OK for Multi-Dose Pen

Wall Street Journal 23 Feb 2026
The company said the weight-loss drug will be available at the same self-pay price in either the single-dose vial format or the multi-dose pen that delivers four weekly injections from a single device ... .
Edit

Novo Nordisk shares fall 16% as new obesity drug trails Eli Lilly

The Times/The Sunday Times 23 Feb 2026
CagriSema achieved a 23% weight ...
Edit

Eli Lilly has already won the weight loss drug battle, says Mizuho's Jared Holz

CNBC 23 Feb 2026
Sarat Sethi, DCLA, and Jared Holz, Mizuho health care sector strategist, join 'Power Lunch' to discuss Holz thoughts on the weight loss drug 'war' ... .
Edit

Novo Nordisk's CagriSema Trial Deals a Blow in Obesity Drug Rivalry With Eli Lilly

US News 23 Feb 2026
COPENHAGEN, Feb 23 (Reuters) - Novo Nordisk's next-generation obesity drug CagriSema was ⁠less ⁠effective than Eli Lilly's tirzepatide in a ⁠... .
Edit

Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push

Invezz 23 Feb 2026
Eli Lilly is trying to make that routine feel less like a chore. The company says it has launched a new Zepbound KwikPen that holds a month’s worth of tirzepatide, four weekly doses in a single multi-dose device.Eli Lilly's Zepbound KwikPen.
Edit

Eli Manning reacts to latest Pro Football Hall of Fame snub

New York Post 23 Feb 2026
Eli Manning is not losing any sleep over his latest Pro Football Hall of Fame snub ... Eli Manning in action against the New York Jets on December 24, 2011 at MetLife Stadium in East Rutherford, New Jersey.
Edit

Why Eli Lilly is suddenly pulling ahead in the GLP-1 weight-loss race

Fast Company 23 Feb 2026
It’s a good day to be the pharmaceutical giant Eli Lilly ... Per a press release , the KwikPen contains a months-worth of Zepbound, Eli Lilly’s GLP-1 designed to combat obesity, and it’s designed to make taking the medicine more convenient.
Edit

Eli Lilly (LLY) Stock Is Up, What You Need To Know

The Call 23 Feb 2026
Shares of global pharmaceutical company Eli Lilly (NYSE ... The results reinforced investor confidence in Eli Lilly's competitive edge in the rapidly growing weight-loss market ... Is now the time to buy Eli ...

Article Search

tools
×
×
×
×